NewslettersImmunology of Infectious Disease NewsMerck’s Next-Gen Pneumococcal Vaccine Slated for July Phase III after Two-Part WinBy Danielle Corrigan - June 22, 2022077One of Merck’s next-generation pneumococcal vaccines has sailed through a mid-stage trial and is being readied for a Phase III study in July.[Fierce Biotech]Press Release